Variable Interferences Dictate Different Cutoffs for Aldosterone Measured by Liaison and iSYS Chemiluminescence Immunoassays for the Seated Saline Suppression Test
BACKGROUND: Variable macromolecular-related interferences with different chemiluminescence immunoassays (CLIA) of plasma aldosterone, particularly at low concentrations during confirmatory tests, are a previously unrecognized problem. We therefore hypothesized that cutoffs for measurements of aldosterone for the seated saline suppression test require tailoring according to the particular immunoassay. METHODS: Multicenter study involving 609 patients with suspected primary aldosteronism who underwent seated saline suppression tests with aldosterone measured by liquid chromatography-mass spectrometry (LC-MS/MS) compared with iSYS or Liaison CLIAs in 285 and 286 respective patients and a different LC-MS/MS method in 38 others. Cutoffs for plasma aldosterone were derived from receiver operating characteristic curves after classification of patients with (n=181) and without primary aldosteronism (n=336) by methods independent of confirmatory tests. For 92 patients classifications were not achieved. RESULTS: Youden's-index derived cutoffs for postsaline infusion plasma aldosterone were 300 and 272 pmol/L for measurements by respective Liaison and iSYS CLIAs compared with 169 pmol/L by LC-MS/MS. At those cutoffs, respective diagnostic sensitivities for Liaison and iSYS immunoassays and LC-MS/MS were 90% (CI, 84-97), 91% (CI, 86-97), and 98% (CI, 96-100) with specificities of 86% (CI, 80-91), 94% (CI, 80-91), and 90% (CI, 86-93). Improved disease confirmation according to specificities of 95% for measurements by Liaison and iSYS CLIAs and LC-MS/MS were provided by respective cutoffs of 436, 297, and 243 pmol/L but with reduced sensitivities of 64% (CI, 53-75), 85% (CI, 78-92), and 78% (CI, 72-84). CONCLUSIONS: Cutoffs for CLIA-based measurements of aldosterone during the seated saline suppression test are higher than those for LC-MS/MS and vary according to the specific immunoassay. Gray areas around cutoffs, particularly extensive for the Liaison CLIA, must also be considered. REGISTRATION: https://drks.de/search/en/trial/DRKS00017084.
Authors
- Christina Pamporaki (ORCID: https://orcid.org/0000-0003-0772-1604)
- Hanna Remde (ORCID: https://orcid.org/0000-0002-3499-5910)
- Jacques W.M. Lenders (ORCID: https://orcid.org/0000-0002-7658-4466)
- Felix Beuschlein (ORCID: https://orcid.org/0000-0001-7826-3984)
- Martín Reincke (ORCID: https://orcid.org/0000-0002-9817-9875)
- Andrea Rita Horvath (ORCID: https://orcid.org/0000-0002-7474-3240)
- Tracy Ann Williams (ORCID: https://orcid.org/0000-0002-2388-6444)
- Carmina Teresa Fuß (ORCID: https://orcid.org/0000-0002-1466-5287)
- Graeme Eisenhofer (ORCID: https://orcid.org/0000-0002-8601-9903)
- Jun Yang (ORCID: https://orcid.org/0000-0003-4620-4976)
Institutions
- The University of Sydney (AU)
- University of Zurich (CH)
- University of Würzburg (DE)
- Radboud University Medical Center (NL)
- University Hospital of Zurich (CH)
- Prince of Wales Hospital (AU)
- Universitätsklinikum Würzburg (DE)
- University Hospital Carl Gustav Carus (DE)
- Monash University (AU)
- Technische Universität Dresden (DE)
- Ludwig-Maximilians-Universität München (DE)
Publication Details
- Journal
- Journal of the American Heart Association
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1161/jaha.126.051573
- Primary Topic
- Hormonal Regulation and Hypertension
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Deutsche Forschungsgemeinschaft
- Medical Research Future Fund